Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.03 |